Interactive Financial Charts Not Available

Medpace Holdings (MEDP) | Financial Analysis & Statements

Medpace Holdings Inc. | Large-cap | Healthcare

$463.64

2.27%

Medpace Holdings vs Thermo Fisher Medpace Holdings vs Danaher Medpace Holdings vs Idexx Laboratories Medpace Holdings vs Agilent Technologies Medpace Holdings vs Iqvia Holdings Medpace Holdings vs S&P 500 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 558.6M

Gross Profit 178.4M 31.93%

Operating Income 113.5M 20.32%

Net Income 114.6M 20.52%

EPS (Diluted) $3.67

Balance Sheet Metrics

Total Assets 1.9B

Total Liabilities 1.3B

Shareholders Equity 593.6M

Debt to Equity 2.20

Cash Flow Metrics

Operating Cash Flow 166.5M

Free Cash Flow 115.8M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Medpace Holdings Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue i	2.1B	1.9B	1.5B	1.1B	925.9M
Cost of Goods Sold i	1.5B	1.4B	1.0B	814.2M	647.2M
Gross Profit i	656.3M	524.5M	432.4M	328.2M	278.7M
Gross Margin % i	31.1%	27.8%	29.6%	28.7%	30.1%
Operating Expenses
Research & Development i	-	-	-	-	-
Selling, General & Administrative i	180.2M	161.4M	131.4M	108.4M	92.2M
Other Operating Expenses i	-	-	-	-	-
Total Operating Expenses i	180.2M	161.4M	131.4M	108.4M	92.2M
Operating Income i	446.9M	336.8M	278.7M	198.6M	167.0M
Operating Margin % i	21.2%	17.9%	19.1%	17.4%	18.0%
Non-Operating Items
Interest Income i	-	-	-	-	-
Interest Expense i	-	-	-	-	-
Other Non-Operating Income	4.1M	-655.0K	7.1M	3.3M	1.2M
Pre-tax Income i	475.9M	335.7M	282.9M	201.9M	168.5M
Income Tax i	71.5M	52.9M	37.5M	20.0M	23.1M
Effective Tax Rate % i	15.0%	15.8%	13.3%	9.9%	13.7%
Net Income i	404.4M	282.8M	245.4M	181.8M	145.4M
Net Margin % i	19.2%	15.0%	16.8%	15.9%	15.7%
Key Metrics
EBITDA i	476.6M	365.1M	297.2M	217.0M	186.1M
EPS (Basic) i	$13.06	$9.20	$7.57	$5.06	$4.07
EPS (Diluted) i	$12.63	$8.88	$7.28	$4.81	$3.84
Basic Shares Outstanding i	30957000	30722000	32388000	35862000	35635000
Diluted Shares Outstanding i	30957000	30722000	32388000	35862000	35635000

Income Statement Trend

Medpace Holdings Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets
Cash & Equivalents i	669.4M	245.4M	28.3M	461.3M	277.8M
Short-term Investments i	-	-	-	-	-
Accounts Receivable i	291.1M	275.9M	213.2M	150.5M	137.9M
Inventory i	-	-	-	-	-
Other Current Assets	63.4M	50.0M	52.3M	43.2M	34.9M
Total Current Assets i	1.0B	593.8M	334.0M	690.9M	473.7M
Non-Current Assets
Property, Plant & Equipment i	174.3M	184.7M	170.9M	157.5M	137.9M
Goodwill i	1.4B	1.4B	1.4B	1.4B	1.4B
Intangible Assets i	34.4M	35.8M	38.0M	41.4M	46.5M
Long-term Investments	-	-	-	-	-
Other Non-Current Assets	122.6M	99.4M	69.2M	42.6M	9.3M
Total Non-Current Assets i	1.1B	1.1B	1.0B	969.0M	917.0M
Total Assets i	2.1B	1.7B	1.4B	1.7B	1.4B
Liabilities
Current Liabilities
Accounts Payable i	32.5M	31.9M	33.1M	25.7M	26.6M
Short-term Debt i	-	-	50.0M	-	-
Current Portion of Long-term Debt	-	-	-	-	-
Other Current Liabilities	53.6M	40.4M	47.5M	27.6M	23.5M
Total Current Liabilities i	1.1B	925.1M	803.5M	557.2M	440.1M
Non-Current Liabilities
Long-term Debt i	126.2M	142.1M	138.9M	131.0M	115.1M
Deferred Tax Liabilities i	1.8M	2.4M	1.1M	1.1M	13.6M
Other Non-Current Liabilities	42.7M	28.2M	22.7M	17.7M	16.1M
Total Non-Current Liabilities i	170.8M	172.7M	162.6M	149.8M	144.8M
Total Liabilities i	1.3B	1.1B	966.1M	707.0M	584.9M
Equity
Common Stock i	306.0K	308.0K	309.0K	360.0K	355.0K
Retained Earnings i	8.2M	-221.6M	-359.8M	235.0M	115.2M
Treasury Stock i	12.2M	12.3M	12.5M	5.4M	5.6M
Other Equity	-	-	-	-	-
Total Shareholders Equity i	825.5M	559.0M	386.4M	952.9M	805.8M
Key Metrics
Total Debt i	126.2M	142.1M	188.9M	131.0M	115.1M
Working Capital i	-75.3M	-331.3M	-469.5M	133.7M	33.5M

Balance Sheet Composition

Medpace Holdings Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income i	404.4M	282.8M	245.4M	181.8M	145.4M
Depreciation & Amortization i	29.3M	26.3M	22.3M	21.1M	19.5M
Stock-Based Compensation i	25.5M	20.5M	21.4M	14.5M	13.8M
Working Capital Changes i	152.4M	21.4M	63.8M	49.7M	45.8M
Operating Cash Flow i	604.0M	348.3M	345.7M	246.3M	238.2M
Investing Activities
Capital Expenditures i	-36.5M	-36.6M	-36.9M	-28.3M	-31.3M
Acquisitions i	-	-	-	-	-
Investment Purchases i	-	-	-	-	-
Investment Sales i	-	-	-	-	-
Investing Cash Flow i	-28.3M	-34.6M	-38.7M	-31.4M	-31.2M
Financing Activities
Share Repurchases i	-169.9M	-144.0M	-847.8M	-62.1M	-98.3M
Dividends Paid i	-	-	-	-	-
Debt Issuance i	-	-	-	-	-
Debt Repayment i	0	-155.0M	-274.2M	0	0
Financing Cash Flow i	-169.9M	-349.0M	-1.1B	-62.1M	-98.3M
Free Cash Flow i	572.3M	396.7M	351.2M	235.1M	227.3M
Net Change in Cash i	405.8M	-35.3M	-765.0M	152.8M	108.7M

Cash Flow Trend

Medpace Holdings Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 34.23

Forward P/E 36.88

Price to Book 74.89

Price to Sales 5.80

PEG Ratio 3.15

Profitability Ratios

Profit Margin 18.74%

Operating Margin 20.94%

Return on Equity 89.39%

Return on Assets 17.09%

Financial Health

Current Ratio 0.43

Debt to Equity 86.93

Beta 1.43

Per Share Data

EPS (TTM) $13.46

Book Value per Share $6.15

Revenue per Share $73.80

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
medp	12.9B	34.23	74.89	89.39%	18.74%	86.93
Thermo Fisher	184.1B	28.17	3.64	13.42%	15.24%	69.62
Danaher	151.0B	44.88	2.89	6.68%	14.21%	35.45
Idexx Laboratories	50.9B	53.10	34.98	64.87%	24.41%	84.81
Agilent Technologies	33.3B	28.78	5.42	18.88%	17.59%	60.04
Iqvia Holdings	32.7B	27.94	5.66	19.79%	7.88%	272.12

Financial data is updated regularly. All figures are in the company's reporting currency.